Cyclacel Pharmaceuticals, INC. (BGMSP) — DEFA14A Filings

All DEFA14A filings from Cyclacel Pharmaceuticals, INC.. Browse 2 DEFA14A reports with AI-powered summaries and risk analysis.

DEFA14A Filings (2)

Cyclacel Pharmaceuticals Files Proxy Materials — Aug 25, 2025 Risk: low
Cyclacel Pharmaceuticals, Inc. filed a Definitive Additional Materials (DEFA14A) on August 25, 2025. This filing is related to proxy materials and does not requ
Cyclacel Pharma Executive Compensation Details Revealed — Jun 25, 2025 Risk: low
Cyclacel Pharmaceuticals, Inc. filed a DEFA14A on June 25, 2025, detailing executive compensation for the fiscal years ending December 31, 2024, 2023, and 2022.

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX